Dyne Therapeutics Ownership | Who Owns Dyne Therapeutics?
Dyne Therapeutics Ownership Summary
Dyne Therapeutics is owned by 110.60% institutional investors, 0.87% insiders. Blackrock is the largest institutional shareholder, holding 9.11% of DYN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.59% of its assets in Dyne Therapeutics shares.
DYN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Dyne Therapeutics | 110.60% | 0.87% | -11.48% |
Sector | Healthcare Stocks | 56.95% | 9.28% | 33.77% |
Industry | Biotech Stocks | 68.60% | 8.91% | 22.49% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 7.39M | 9.11% | $260.69M |
Atlas venture life science advisors | 8.02M | 7.95% | $188.94M |
Fmr | 8.00M | 7.93% | $188.41M |
Blackrock funding, inc. /de | 7.95M | 7.88% | $187.29M |
Janus henderson group | 7.38M | 7.31% | $173.81M |
Vanguard group | 6.70M | 6.65% | $157.94M |
Ra capital management | 6.38M | 6.33% | $150.34M |
Fcpm iii services b.v. | 5.46M | 5.42% | $128.70M |
Rtw investments, lp | 5.22M | 5.17% | $122.95M |
State street | 3.72M | 3.68% | $87.58M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Atlas venture life science advisors | 8.02M | 23.05% | $188.94M |
Fcpm iii services b.v. | 5.46M | 21.73% | $128.70M |
Mpm asset management | 682.38K | 12.92% | $16.08M |
Vida ventures advisors | 407.50K | 6.56% | $9.60M |
Tcg crossover management | 2.65M | 6.10% | $62.44M |
Vr adviser | 2.17M | 3.51% | $51.22M |
Vivo capital | 1.11M | 2.94% | $26.27M |
Octagon capital advisors lp | 668.00K | 2.59% | $15.74M |
Ra capital management | 6.38M | 2.00% | $150.34M |
Rtw investments, lp | 5.22M | 1.86% | $122.95M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 7.39M | 0.01% | 2.00M |
Jefferies financial group | 1.80M | 0.25% | 1.80M |
Norges bank | 950.10K | 0.00% | 950.10K |
Point72 asset management | 924.68K | 0.05% | 822.20K |
Braidwell lp | 681.18K | 0.48% | 681.18K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 5.22M | 1.86% | -1.60M |
Deep track capital, lp | 2.00M | 1.76% | -1.28M |
Fmr | 8.00M | 0.01% | -1.03M |
First light asset management | 420.43K | 0.95% | -836.85K |
Avoro capital advisors | - | - | -650.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Jefferies financial group | 1.80M | 0.25% | 1.80M | $42.41M |
Norges bank | 950.10K | 0.00% | 950.10K | $22.38M |
Braidwell lp | 681.18K | 0.48% | 681.18K | $16.05M |
Frontier capital management | 298.05K | 0.07% | 298.05K | $7.02M |
Cubist systematic strategies | 119.06K | 0.02% | 119.06K | $2.81M |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Headlands | -1.00 |
Allworth financial lp | -5.00 |
Nelson, van denburg & campbell wealth management group | -9.00 |
Cva family office | -12.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 204 | -1.45% | 111,580,268 | -0.38% | 110 | 0.90% | 105 | -10.26% | 62 | 14.81% |
Sep 30, 2024 | 207 | 5.08% | 111,994,758 | 0.90% | 111 | 0.59% | 117 | -7.14% | 54 | 17.39% |
Jun 30, 2024 | 197 | 12.57% | 110,993,406 | 16.43% | 136 | 0.99% | 126 | -1.56% | 46 | 58.62% |
Mar 31, 2024 | 175 | 28.68% | 95,333,552 | 36.34% | 117 | 0.91% | 128 | 85.51% | 29 | -27.50% |
Dec 31, 2023 | 136 | 13.33% | 69,922,234 | 16.75% | 113 | 1.19% | 69 | 16.95% | 40 | 25.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.63M | 2.59% | 3.17K |
iShares Russell 2000 ETF | 2.24M | 2.21% | -17.05K |
Fidelity Growth Compy Commingled Pl S | 1.84M | 1.80% | 18.42K |
Fidelity Growth Compy Commingled Pl O | 1.79M | 1.78% | 348.61K |
SPDR® S&P Biotech ETF | 1.81M | 1.77% | -17.58K |
Janus Henderson Global Life Sciences D | 1.43M | 1.41% | 7.37K |
Janus Henderson Global Life Sciences | 1.41M | 1.39% | -12.05K |
Fidelity Growth Company Fund | 1.30M | 1.28% | -26.66K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.20M | 1.18% | 25.24K |
Janus Henderson Glb Life Scn I2 USD | 1.13M | 1.11% | -13.86K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 18, 2025 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | $34.71K |
Dec 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | $65.63K |
Dec 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | $40.91K |
Dec 09, 2024 | Kersten Dirk | - | Sell | $1.00M |
Dec 06, 2024 | Kersten Dirk | - | Sell | $2.98M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 1 |
2024 Q4 | - | 24 |
2024 Q3 | 2 | 79 |
2024 Q2 | - | 26 |
2024 Q1 | 2 | 122 |
DYN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools